JPS608800B2 - How to measure peroxidase activity - Google Patents
How to measure peroxidase activityInfo
- Publication number
- JPS608800B2 JPS608800B2 JP8270377A JP8270377A JPS608800B2 JP S608800 B2 JPS608800 B2 JP S608800B2 JP 8270377 A JP8270377 A JP 8270377A JP 8270377 A JP8270377 A JP 8270377A JP S608800 B2 JPS608800 B2 JP S608800B2
- Authority
- JP
- Japan
- Prior art keywords
- peroxidase
- enzyme
- protein
- proteins
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 102000003992 Peroxidases Human genes 0.000 title claims description 48
- 108040007629 peroxidase activity proteins Proteins 0.000 title claims description 40
- 230000000694 effects Effects 0.000 title claims description 38
- 102000004169 proteins and genes Human genes 0.000 claims description 33
- 108090000623 proteins and genes Proteins 0.000 claims description 33
- 238000000034 method Methods 0.000 claims description 17
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 13
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 238000006911 enzymatic reaction Methods 0.000 claims description 4
- 238000012921 fluorescence analysis Methods 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 description 32
- 102000004190 Enzymes Human genes 0.000 description 20
- 108090000790 Enzymes Proteins 0.000 description 20
- 229940088598 enzyme Drugs 0.000 description 20
- 238000005259 measurement Methods 0.000 description 19
- 239000000243 solution Substances 0.000 description 15
- 230000035945 sensitivity Effects 0.000 description 12
- QRMZSPFSDQBLIX-UHFFFAOYSA-N homovanillic acid Chemical compound COC1=CC(CC(O)=O)=CC=C1O QRMZSPFSDQBLIX-UHFFFAOYSA-N 0.000 description 10
- 239000000758 substrate Substances 0.000 description 9
- 241000196324 Embryophyta Species 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 108700020962 Peroxidase Proteins 0.000 description 7
- 102000004196 processed proteins & peptides Human genes 0.000 description 7
- 239000000427 antigen Substances 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 108091007433 antigens Proteins 0.000 description 6
- 239000011541 reaction mixture Substances 0.000 description 5
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000007853 buffer solution Substances 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 238000007557 optical granulometry Methods 0.000 description 3
- 238000011002 quantification Methods 0.000 description 3
- 240000003291 Armoracia rusticana Species 0.000 description 2
- 235000011330 Armoracia rusticana Nutrition 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108060006006 Cytochrome-c peroxidase Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 230000003139 buffering effect Effects 0.000 description 2
- 239000005018 casein Substances 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 235000021240 caseins Nutrition 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000002532 enzyme inhibitor Substances 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 238000002372 labelling Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- OBMZMSLWNNWEJA-XNCRXQDQSA-N C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 Chemical compound C1=CC=2C(C[C@@H]3NC(=O)[C@@H](NC(=O)[C@H](NC(=O)N(CC#CCN(CCCC[C@H](NC(=O)[C@@H](CC4=CC=CC=C4)NC3=O)C(=O)N)CC=C)NC(=O)[C@@H](N)C)CC3=CNC4=C3C=CC=C4)C)=CNC=2C=C1 OBMZMSLWNNWEJA-XNCRXQDQSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 102000001189 Cyclic Peptides Human genes 0.000 description 1
- 108010069514 Cyclic Peptides Proteins 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000008857 Ferritin Human genes 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 238000008416 Ferritin Methods 0.000 description 1
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 1
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000008015 Hemeproteins Human genes 0.000 description 1
- 108010089792 Hemeproteins Proteins 0.000 description 1
- 108010044467 Isoenzymes Proteins 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000036675 Myoglobin Human genes 0.000 description 1
- 108010062374 Myoglobin Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 101710176384 Peptide 1 Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 101000971427 Plasmodium falciparum Knob-associated histidine-rich protein Proteins 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 244000300264 Spinacia oleracea Species 0.000 description 1
- 235000009337 Spinacia oleracea Nutrition 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-N Tyramine Natural products NCCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-N 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 238000012742 biochemical analysis Methods 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000009849 deactivation Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 230000002327 eosinophilic effect Effects 0.000 description 1
- -1 etc.) Proteins 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000000984 immunochemical effect Effects 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000004204 optical analysis method Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 238000006395 oxidase reaction Methods 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 235000021395 porridge Nutrition 0.000 description 1
- 108020001775 protein parts Proteins 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960003732 tyramine Drugs 0.000 description 1
- DZGWFCGJZKJUFP-UHFFFAOYSA-O tyraminium Chemical compound [NH3+]CCC1=CC=C(O)C=C1 DZGWFCGJZKJUFP-UHFFFAOYSA-O 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【発明の詳細な説明】
本発明は蟹光分析法によるベルオキシダーゼ活性の新規
な高感度測定方法に関する心ベルオキシダーゼは過酸化
水素(日202)の共存下で種々の基質(水素供与体)
の酸化反応を触媒する酵素で既に植物及び動物組織由来
の各種のベルオキシダーゼ(Peroxi畝ses)、
牛乳中に含まれるラクトベルオキシダーゼ(Lacto
peroxi船ses)酵母菌に含まれるチトクローム
Cベルオキシダーゼ(CytochromeC per
oxi船se)、腸球菌産生のベルオキシダーゼ、及び
白血球や骨髄のェオシン好性細胞に含まれるウェルドベ
ルオキシダーゼ(Verdoperxjdase)等が
知られている。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a novel and highly sensitive method for measuring peroxidase activity using crab photoanalysis.
Various peroxidases derived from plant and animal tissues are already known as enzymes that catalyze the oxidation reaction of
Lactoberoxidase (Lacto) contained in milk
Cytochrome C peroxidase (Cytochrome C peroxidase contained in yeast)
oxidase), peroxidase produced by enterococci, and weld peroxidase (Verdoperxjdase) contained in leukocytes and eosinophilic cells of the bone marrow.
本発明に用いられるベルオキシダーゼとしてはこれら各
種のベルオキシダーゼが対象となるが、その中でも殊に
植物由来のベルオキシダーゼが主要な対象である。植物
ベルオキシダーゼは、西洋ワサビの根、大根、蕪、ソラ
マメやホウレンソウの葉、小麦の舷、等各種の植物界に
広く分布する。更に植物ベルオキシダーゼはその給源と
なる植物の種類を問わずその補欠分子族のへムがいずれ
もプロトヘムであることや、酵素蛋白質部分の有する滴
電状態に基いて酸性、中性、塩基性の酵素に大別される
などベルオキシダーゼの諸性質には共通性が極めて高く
、とりわけ西洋ワサビ(Homeradish)由来の
ベルオキシダーゼ(以下HRPと略す)が通常最も代表
的なものとされている。The peroxidases used in the present invention include these various types of peroxidases, but plant-derived peroxidases are particularly important. Plant peroxidase is widely distributed in various plant kingdoms, such as the roots of horseradish, radish, turnips, leaves of fava beans and spinach, and the stems of wheat. Furthermore, regardless of the type of plant that is the source of plant peroxidase, the prosthetic group heme is all protoheme, and based on the electrostatic state of the enzyme protein part, it can be acidic, neutral, or basic. The properties of peroxidases, such as being broadly classified into enzymes, are extremely common, and in particular, peroxidase derived from horseradish (hereinafter abbreviated as HRP) is usually considered to be the most representative.
植物ベルオキシダーゼ例えばHRPは最も古くからの抽
出分離及び精製化が進みH202や使用基質の直接定量
を目的とした生化学分析法や、糖類、アミノ酸、有機塩
基、コレステロール等の測定対象物から&02を生成す
る酸化酵素反応とベルオキシダーゼによる日202の定
量との組合せによって測定対象物の徴量側定を目指すな
ど臨床化学分野において広く使用されている。Plant peroxidase For example, HRP has been extracted, separated and purified since the earliest times, and has been used in biochemical analysis methods for the direct quantification of H202 and substrates used, as well as &02 from measurement targets such as sugars, amino acids, organic bases, and cholesterol. It is widely used in the field of clinical chemistry to aim at determining the characteristics of a measurement target by combining the oxidase reaction produced and the quantification using peroxidase.
したがってベルオキシダーゼ活性が高感度に測定出来る
ことによりベルオキシダーゼ自身の高感度な検出は勿論
のこと、この反応に関与するり02、基質、必要性によ
って酵素に対する阻害力との相関性を測定原理とする各
種の酵素阻害剤等の徴量測定、更には日202の微量測
定に基づく上記の目的測定対象物の超微量測定も可能に
なって臨床診断上の意義は極めて大である。また一方生
体内徴量成分の超微量測定法の一つとして近年急速に発
展して来た酵素免疫定量法或いは免疫組織化学的手法に
よる抗原検出のための酵素抗体法等においては抗原や抗
体の標識用酵素としてベルオキシダーゼ例えばHRPを
活用する事例が非常に多い。前者の酵素免疫定量法にお
いてはその測定システム上からも明らかな如く標識酵素
の活性が高感度に測定出来ればその標識酵素量の徴量測
定が可能となり、その結果として測定対象物となる各種
の抗原及び抗体の超微量の定量化が達成される。この論
理はHRP等植物ベルオキシダーゼを標識酵素とする酵
素抗体法の場合についても通用し、微細組織中の表存抗
原や内部抗原の局在性をより少量の試料についてより詳
細に追跡する場合にも役立つ。このようにベルオキシダ
ーゼ活性の高感度測定方法を確立することは唯単にベル
オキシダーゼ酵素量の徴量な測定が容易になるばかりで
なく、比02被酸化性基質或いは酵素阻害剤の微量測定
更には上記の如く生体出徴量成分の生化学的または酵素
免疫化学的測定分野或いは免疫組織化学分野等への広範
囲な応用が可能となる。HRPをはじめとする各種ベル
オキシダーゼの活性の測定方法としては従釆は専ら可視
部吸光法が採用されているが、可視部吸光法に共通する
性質としてその測定感度は一般的に相当に低い欠点があ
った。Therefore, by being able to measure peroxidase activity with high sensitivity, we can not only detect peroxidase itself with high sensitivity, but also use the measurement principle to determine the correlation between peroxidase itself and its inhibitory power depending on the substrate and necessity. It has become possible to measure the amounts of various enzyme inhibitors and the like, and also to measure ultra-trace amounts of the above-mentioned target analytes based on trace amounts measured on a day-202 basis, which is of great significance in terms of clinical diagnosis. On the other hand, enzyme-linked immunoassay and enzyme-linked immunoassay for detecting antigens using immunohistochemical techniques, which have been rapidly developed in recent years as a method for measuring ultra-trace amounts of in-vivo components, are used to detect antigens and antibodies. There are many cases in which peroxidase such as HRP is utilized as a labeling enzyme. In the former enzyme immunoassay method, as is clear from the measurement system, if the activity of the labeled enzyme can be measured with high sensitivity, it is possible to measure the amount of the labeled enzyme, and as a result, the amount of the labeled enzyme can be measured. Ultratrace quantification of antigen and antibody is achieved. This logic also applies to enzyme antibody methods that use plant peroxidase such as HRP as the labeling enzyme, and is useful when tracking the localization of surface antigens and internal antigens in microscopic tissues in more detail in smaller samples. is also helpful. Establishing a highly sensitive measuring method for peroxidase activity will not only facilitate the precise measurement of the amount of peroxidase enzyme, but also facilitate the measurement of minute amounts of oxidizable substrates or enzyme inhibitors. As described above, a wide range of applications is possible in the field of biochemical or enzyme immunochemical measurement of biologically detected components, the field of immunohistochemistry, etc. The conventional method for measuring the activity of various peroxidases including HRP is the visible absorption method, but a common characteristic of the visible absorption method is that its measurement sensitivity is generally quite low. was there.
一方先にギルバウト等はホモバリニン酸を基質する新規
な蟹光分析法を報告した〔Guiltba山t,G,G
,et,al:Anal,Chem,39(No2)2
71(1967),ibid,40(Nol)190〜
196(19粥),ibid,40(No8)1256
〜1263(1968)〕この蟹光分析法は中性乃至弱
アルカリ性の液性下で日202の共存によって安定な非
蟹光性基質であるホモバニリン酸を高度の蟹光性物質に
変換した後その蟹光強度を測定することによってベルオ
キシダーゼ活性を求めるもので、従来の可視部吸光法採
用時に比較して全般的に測定感度は高まるものの、ベル
オキシダーゼを使用した多数の事例において未だ不充分
な現状にあった。On the other hand, Guilbout et al. previously reported a new crab optical analysis method using homovalinic acid as a substrate [Guilbout et al.
,et,al:Anal,Chem,39(No2)2
71 (1967), ibid, 40 (Nol) 190~
196 (19 porridge), ibid, 40 (No8) 1256
~1263 (1968)] This crab photoanalysis method involves converting homovanillic acid, a stable non-carifluorescent substrate, into a highly photochromic substance by the coexistence of 202 in a neutral to weakly alkaline solution. Peroxidase activity is determined by measuring the intensity of light, and although the measurement sensitivity is generally higher than when using the conventional visible absorption method, it is still insufficient in many cases where peroxidase is used. It was there.
こうした状況の中で本発明者は前記公知方法の欠点を改
良すべ〈鋭意研究を重ねた結果、過酸化水素の共存下で
非鞍光性の基質にベルオキシダーゼを作用せしめ生成し
た後光性物質の示す後光強度によりベルオキシダーゼ活
性を求めることを測定原理とする蟹光分析法によるベル
オキシダーゼ活性の測定方法において、酸性下で且つベ
ルオキシダーゼ活性を有しない蛋白質あるいはべプチド
の存在下で酵素反応、例えば、ホモバニリン酸を基質と
し過酸化水素の共存下でベルオキシダーゼを作用させて
後光性物質を生成せしめる反応を行うことによって従来
法例えば、この分野において最も代表的なギルバウト等
の方法と比較してベルオキシダーゼ活性が更に感度、精
度、結果の再現性共に極めて高く測定出来ることを見出
して本発明を完成させるにいたつた。即ち、本発明にお
ける酵素反応は酸性下で行う。Under these circumstances, the inventor of the present invention aimed to improve the shortcomings of the above-mentioned known methods.As a result of intensive research, the inventors of the present invention have discovered that a halophotogenic substance is produced by the action of peroxidase on a non-caerilescent substrate in the coexistence of hydrogen peroxide. In a method for measuring peroxidase activity using crab photoanalysis, whose measurement principle is to determine peroxidase activity based on the halo intensity shown by For example, compared with the conventional method, for example, the most representative method in this field, the method of Gilbout et al., by performing a reaction in which homovanillic acid is used as a substrate and peroxidase is activated in the presence of hydrogen peroxide to produce a haloscopic substance. The inventors have now discovered that peroxidase activity can be measured with extremely high sensitivity, accuracy, and reproducibility of results, leading to the completion of the present invention. That is, the enzyme reaction in the present invention is performed under acidic conditions.
この場合のpHは7以下であればよいが、最高の感度を
得るためには酸性下の特定pH領域を選択するのが好ま
しく、通常は特定押領域設定用緩衝液の調製に用いられ
た酸の種類によってpH3.5〜5.0を採用する。本
発明に用いる蛋白質はベルオキシダーゼ活性を有せず、
且つベルオキシダーゼに対して阻害的に作用するもので
なければ如何なる蛋白質でもよく、例えば、人及び動物
由来の血清蛋白(アルプミン及び各種グロプリン)、動
物蛋白(カゼイン、ゼラチン、卵アルブミン等)、蛋白
質材料としての酵素類(卵白リゾチーム、アルドラーゼ
、キモトリブシノーゲンA等)、その他植物蛋白や微生
物産生の蛋白質等の中から適宜選択されるが、通常は牛
血清ァルブミン(斑Aと略す)を採用されることが多い
。In this case, the pH should be 7 or less, but in order to obtain the highest sensitivity, it is preferable to select a specific pH range under acidic conditions. pH 3.5 to 5.0 is adopted depending on the type. The protein used in the present invention does not have peroxidase activity,
Any protein may be used as long as it does not have an inhibitory effect on peroxidase, such as serum proteins derived from humans and animals (alpmin and various globulins), animal proteins (casein, gelatin, egg albumin, etc.), and protein materials. The protein is selected from among enzymes (egg white lysozyme, aldolase, chymotrybusinogen A, etc.), other plant proteins, proteins produced by microorganisms, etc., but bovine serum albumin (abbreviated as plaque A) is usually used. Often.
同様にしてべプチドとしては、ベルオキシダーゼ活性を
有せず、且つベルオキシダーゼの活性発現に対して阻害
作用を有するものでなければ如何なるべブチドでもよく
、また鎖状及び環状べプチドのいずれでもよい。実際的
には蛋白質の部分水解物、化学合成されたもの、或いは
べプチド材料としてのべプチド系抗生物質等が採用され
る。これら蛋白質やべプチドの使用量は極めて少量でよ
く、その至通な使用量は用いる蛋白質やべプチドの種類
或いは添加時期等によって若干異るものの通常は最終的
に測定用試験管中に数山g以上存在せしめる程度で充分
であり、仮に極めて大過剰な量を用いても特に不都合は
みられない。ここで使用される蛋白質やべプチドはその
一種類を単用する以外に更に2種以上を適宜組合せて用
いることも可能である。またこれら蛋白質やべプチド類
を存在せしめる時期についても特に制限はなく、例えば
酵素反応を行わしめる直前に添加してもよく、或いはベ
ルオキシダーゼ溶液または酵素標品の保存開始時にあら
かじめ添加しておき一定期間保存した後に本発明の実施
に当ってその溶液や標品をそのまま使用してもよい、こ
こで本発明の骨子をなす蛋白質やべプチドの添加効果に
ついてその詳細を以下に実施例で示す。実験例 1:酵
素作用PHと斑A添加効否の関係0.1Mークェン酸一
Naあ407緩衝液(pH4.0)0.08M一Na比
P04一NaoH緩衝液(pH7.0)0.1M−トリ
ス(ヒドロキシメチル)アミノメタン一日CI緩衝液(
pH8.50)の一種500〃夕HRP(TypeV1
,RZ:約2.75、活性:約26岬mpmo鉾11i
n Units / の9 り SigmaChemi
calCo、米国より買入)の1ユニット/私液10〃
夕、既AI2.5の2/舷水溶液または純水20仏と、
0.25%ホモバニリン酸水溶液50一夕、0.05%
一日202液50ム夕を含む反応混合液を37.がoで
ゆつくり猿傷し乍ら30分間インキュベートした後1.
25%一KCN液50rそを添加して反応を停止させ更
に0.1N−NaOH2.5の‘を迫添してから日立製
分光蟹光光度計204型を用いて蟹光強度を測定し(励
起波長32仇豚、蟹光波長405肌)で表1の結果を得
た。Similarly, the peptide may be any peptide as long as it does not have peroxidase activity and has an inhibitory effect on the expression of peroxidase activity, and may be either chain or cyclic peptides. . In practice, a partially hydrolyzed protein, a chemically synthesized protein, or a peptide antibiotic as a peptide material is used. The amount of these proteins and peptides used can be extremely small, and although the amount used varies slightly depending on the type of protein or peptide used, the time of addition, etc., there are usually several amounts in the test tube for measurement. It is sufficient that the amount is present in an amount of 1.5 g or more, and no particular disadvantage is observed even if an extremely large excess amount is used. The proteins and peptides used here may be used alone or in combination of two or more. There is also no particular restriction on the timing of making these proteins and peptides present; for example, they may be added just before the enzymatic reaction is completed, or they may be added in advance at the beginning of storage of the peroxidase solution or enzyme preparation and kept at a constant level. After storage for a period of time, the solutions and preparations may be used as they are in carrying out the present invention.The details of the effects of adding proteins and peptides, which form the gist of the present invention, will be shown in Examples below. Experimental example 1: Relationship between enzyme action PH and effectiveness of plaque A addition 0.1M - citrate - Na 407 buffer (pH 4.0) 0.08M - Na ratio P04 - NaoH buffer (pH 7.0) 0.1M - Tris(hydroxymethyl)aminomethane one day CI buffer (
pH 8.50) 500 yen HRP (Type V1)
, RZ: Approx. 2.75, Activity: Approx. 26 Misaki MPMO Hoko 11i
n Units / 9 ri SigmaChemi
CalCo (purchased from the US) 1 unit/private liquid 10〃
In the evening, add 20 liters of water solution or pure water with an AI of 2.5,
0.25% homovanillic acid aqueous solution 50 overnight, 0.05%
37. The reaction mixture containing 50 m2 of 202 liquid per day. 1. After incubating for 30 minutes while slowly incubating the monkey with o.
After adding 50 r of 25% KCN solution to stop the reaction and adding 0.1N NaOH2.5', the crab light intensity was measured using a Hitachi spectrophotometer model 204 ( The results shown in Table 1 were obtained using an excitation wavelength of 32° and an excitation wavelength of 405°.
表1
実験例 2:各種蛋白質の添加効果
0.1M−クエン酸−Na2B407緩衝液(PIH.
0)または0.09M−NaQP04−NaOH緩衝液
(pH4.5)500ム〆、実験例1に示したHRPI
.19二1ニツトノ凧【液10仏夕、蛋白質溶液12.
5の夕/私の20仏そを用いて実験例1と同様な操作を
施し、表2の結果を得た。Table 1 Experimental example 2: Effect of addition of various proteins 0.1M-citric acid-Na2B407 buffer (PIH.
0) or 0.09M-NaQP04-NaOH buffer (pH 4.5) 500 μM, HRPI shown in Experimental Example 1
.. 1921 Nitsutonokite [liquid 10 butsuyu, protein solution 12.
The same operation as in Experimental Example 1 was performed using 20 pieces of rice on the 5th evening, and the results shown in Table 2 were obtained.
表2
☆1:ァ−マ−ファーマシィティヵル社(米国)より買
入☆2:べ−リンガーマンハィム社(西独)より買入実
験例 3:蛋白質の添加量0.1M−クエン酸Na2B
407緩衝液(pH4.0)500仏〆を用い下表に記
載し★量の牛血清アルブミンまたはミルクカゼインぞ含
む液20仏夕を添加した後、実験例1と同様な操作を施
して下表3のHRP活性値を得た。Table 2 ☆1: Purchased from Pharma Pharmaceutical (USA) ☆2: Purchased from Boehringer Mannheim (West Germany) Experimental example 3: Addition amount of protein 0.1M citric acid Na2B
Using 407 buffer solution (pH 4.0) with 500 ml of buffer solution, add 20 ml of a solution containing bovine serum albumin or milk casein in the amount listed in the table below, and then perform the same operation as in Experimental Example 1 to obtain the solution shown in the table below. An HRP activity value of 3 was obtained.
表3
実験例 4:HRP液保存時における聡Aの添加効果実
験例1に示したSi囚ma社のHR・P或いは東洋紡綾
(株)より買入し たHRP(Basiclsoenz
ymeGrade l−C,RZ:3.4、活性:36
肥mpmo鞍mnUni$/雌)の1×10‐1〜1×
10‐3ユニット/の【液とこのHRP液にBSAを最
終濃度11.2〜12.4の夕/私添加した両者を4℃
の冷蔵庫中に6虫時間放置した後、その10山のこつい
て実験例1に準じてHRP活性を測定し表4の結果を得
た。Table 3 Experimental example 4: Effect of addition of Satoshi A during storage of HRP solution
ymeGrade l-C, RZ: 3.4, activity: 36
Fertilizer mpmo saddle mnUni$/female) 1×10-1 to 1×
10-3 units/solution and BSA were added to this HRP solution at a final concentration of 11.2-12.4 and both were heated at 4℃.
After leaving the samples in a refrigerator for 6 hours, the HRP activity of the 10 samples was measured according to Experimental Example 1, and the results shown in Table 4 were obtained.
但しトHRP活性測定時においては反応混合液中におけ
る斑〜最終濃度が各区共250山/試験管となる如く造
添して補正した。表4
実験例 5:ィンキュべ‐ション時間と斑A添加効果の
関係pH4.0の緩衝液を用い且つBSA250ムg/
試験管を添加した場合と無添加時について実験例1の如
く操作して活性を経時的に測定し、下表5の値を得た。However, when measuring HRP activity, correction was made by adding so that the final concentration in the reaction mixture was 250 peaks/test tube for each group. Table 4 Experimental example 5: Relationship between incubation time and effect of adding plaque A using a pH 4.0 buffer solution and 250 mg of BSA/
The activity was measured over time in the same manner as in Experimental Example 1 with and without addition of the test tube, and the values shown in Table 5 below were obtained.
表5
以上、表1〜5の結果から明らかな如く、ベルオキシダ
ーゼ活性測定時における蛋白質の添加効果は、その酵素
作用を酸性pH城下で行わしめる場合において顕著に認
められ、酵素作用に際して至通なpHを維持しうる緩衝
能を有するものであれば、緩衝液の調製に用いられた酸
類及びアルカリ類の種類如何とは本質的に関係なく発揮
される。Table 5 As is clear from the results in Tables 1 to 5, the effect of adding protein during peroxidase activity measurement is remarkable when the enzyme action is carried out at an acidic pH; As long as it has a buffering capacity that can maintain pH, the buffering capacity will be exhibited essentially regardless of the type of acids and alkalis used to prepare the buffer.
これに対し、先に示したギルバウト等の報告に基づく中
性乃至アルカリ性下では有意な添加効果を認めないばか
りでなく、その蛋白質の添加は却って阻害的に働いた。
ここで用いる蛋白質或にはべプチドとしてはBSAをは
じめとする血清蛋白質、動物由来蛋白質、蛋白質材料と
しての酵素類或し、はべプチド系抗生物質等生物活性を
有する蛋白質及び特殊な活性を有しない蛋白質のいずれ
でもよく、その蛋白質の給源、分子量の大小、化学構造
、ロット差、蛋白質標品調製法の如何を問わない。更に
2種以上の蛋白質を適宜細合せて用いることも可能であ
る。但し、これら各種の蛋白質及びべプチドを構成する
個々のアミノ酸或いはアミノ酸の混合物、更には無機性
のアンモニウム塩類等には蛋白質で観察されたような添
加効果は殆んど期待出来ない。またフェリチン、ミオグ
ロビン、チトクロームC等分子中に金属原子を含む色素
蛋白質は一般的に阻害的に働くためその使用をさげる事
が望ましい。これら蛋白質の至適添加量は用いる蛋白質
やべプチドの種類によって若干異るが、通常各試験管中
1〜6仏g以上あれば充分であり、かと云って極めて大
過剰な量を用いても特に不都合はない。On the other hand, under neutral or alkaline conditions based on the report by Gilbout et al. mentioned above, not only was there no significant addition effect, but the addition of the protein actually acted as an inhibitor.
The proteins or peptides used here include serum proteins such as BSA, animal-derived proteins, enzymes as protein materials, proteins with biological activity such as peptide antibiotics, and proteins with special activities. The source of the protein, its molecular weight, chemical structure, lot difference, and preparation method for protein preparations do not matter. Furthermore, it is also possible to use a suitable combination of two or more types of proteins. However, the effects observed with proteins cannot be expected from individual amino acids or mixtures of amino acids constituting these various proteins and peptides, and even inorganic ammonium salts. Furthermore, since pigment proteins containing metal atoms in their molecules, such as ferritin, myoglobin, and cytochrome C, generally act as inhibitors, it is desirable to reduce their use. The optimal amount of these proteins to be added varies slightly depending on the type of protein or peptide used, but usually 1 to 6 g or more in each test tube is sufficient, but even if extremely excessive amounts are used, There is no particular inconvenience.
次にこれら蛋白質の添加時期に関しては、前述の如くベ
ルオキシダーゼ活性測定用反応混合液の調製時に添加す
るのが通例ではあるが、他にベルオキシダーゼ溶液また
は標品の保存時に,添加する場合もある。殊に保存すべ
きベルオキシダーゼ溶液や標品において酵素量がより希
薄であ,れぱある程保存に際して事前添加する方法がは
るかに有益である。いずれにしてもベルオキシダーゼ活
性の測定時において蛋白質やべプチドが共存すればよく
、その結果としてベルオキシダーゼ活性増大作用と失活
抑制作用の2面的効果が期待出来る。このような本発明
の構成要因をなす蛋白質或し1はべプチドの添加による
ベルオキシダーゼ活性検出の高感度化の現象は酵素の精
製度を反映するRZ値、補欠分子族へム蛋白云々の如何
を問わず各種のベルオキシダーゼ及びその各アィソザィ
ム(isozyme)に、またnativeなべルオキ
シダーゼそのものの他、人工的に化学修飾されたもの、
更には各種の抗原や抗体に標識されたベルオキシダーゼ
、固定化ベルオキシダーゼについても、他方ホモバニリ
ン酸の如きpーオキシ芳香族カルボン酸やチラミン、チ
ロシン等種々の基質を用いた場合についても同様に認め
られる。実際的には姿光強度の測定時において通常使用
される1仇肋セルの代りにミクロセルを用いる等他の測
定操作上の工夫と組合せれば更により少量の試料につい
ても測定可能となる。したがって先願〔特豚昭52一6
6518〕に加えて本発明を実施することにより、特別
な高性能高感度を有する蟹光分析計は不要になって通常
の臨床検査室等に設置されている普通型の蟹光分析計を
用いるだけでベルオキシダーゼ活性、加えて各種生体徴
量成分等がより簡単な操作で且つ更に短時間内に精度、
感度及び再現性共によりよく測定出来て本発明の臨床上
における意義は極めて大である。Next, regarding the timing of addition of these proteins, as mentioned above, it is customary to add them when preparing the reaction mixture for measuring peroxidase activity, but there are also cases where they are added when storing the peroxidase solution or sample. . Particularly in peroxidase solutions and specimens to be stored, the amount of enzyme is more dilute, and the more dilute the enzyme is, the more advantageous it is to pre-add it during storage. In any case, it is sufficient that proteins and peptides are present at the time of measuring peroxidase activity, and as a result, a two-pronged effect of increasing peroxidase activity and suppressing deactivation can be expected. The phenomenon of increasing the sensitivity of peroxidase activity detection by adding protein or peptide 1, which is a constituent factor of the present invention, is due to the RZ value reflecting the degree of purification of the enzyme, prosthetic group heme protein, etc. In addition to various peroxidases and their respective isozymes, as well as native peroxidase itself, artificially chemically modified ones,
Furthermore, the same effect is observed with peroxidase labeled with various antigens and antibodies, and with immobilized peroxidase, as well as with various substrates such as p-oxyaromatic carboxylic acids such as homovanillic acid, tyramine, and tyrosine. . In practice, if this method is combined with other measures for measurement operations, such as using a microcell instead of the single cell that is normally used when measuring the intensity of light, even smaller amounts of samples can be measured. Therefore, the earlier application [Tokubuta 52-16]
By implementing the present invention in addition to [6518], a special high-performance, high-sensitivity crab light analyzer is no longer necessary, and an ordinary crab light analyzer installed in ordinary clinical laboratories etc. can be used. You can easily measure peroxidase activity, as well as various biological signature components, etc., with easier operation and in a shorter time.
The clinical significance of the present invention is extremely great as it allows for better measurement with better sensitivity and reproducibility.
次に実施例により本発明を更に具体的に説明する。Next, the present invention will be explained in more detail with reference to Examples.
但し以下に示す測定事例は本発明実施の単なる一例にす
ぎず、先述した如き本発明の適用範囲を何ら限定するも
のではない。実施例 1:HRP量の測定
0.1M−クエン酸−NaB07緩衝液(pH4.0)
500ム夕、HRP(実験例1で使用したものと同じ)
1×10‐2〜1×10‐3ユニット/机液10仏〆、
BSA(フラクシヨンV、Annour Pharma
ceutje−aICoへ米国より買入)12.5爪9
/の【水溶液または純水20〃そ及び実験例1と同じ基
質液、日202液を含む反応混合液を実験例1に準じて
55分間ィンキュベーションし、更に所定量のKCN及
びNaOH液を添加後1仇蛇セルを用いて蟹光度を測定
し下表6の値を得た。However, the measurement examples shown below are merely examples of implementing the present invention, and do not limit the scope of application of the present invention as described above. Example 1: Measurement of HRP amount 0.1M-citric acid-NaB07 buffer (pH 4.0)
500 mU, HRP (same as used in Experimental Example 1)
1 x 10-2 to 1 x 10-3 units/10 tablets of desk fluid,
BSA (Fraction V, Annour Pharma
Purchased from the US to ceutje-aICo) 12.5 claws 9
A reaction mixture containing an aqueous solution or pure water 20 ㎃, the same substrate solution as in Experimental Example 1, and a 202 ml solution was incubated for 55 minutes according to Experimental Example 1, and further a predetermined amount of KCN and NaOH solutions were added. After adding , the luminous intensity was measured using a 1.0-meter cell and the values shown in Table 6 below were obtained.
即ち、酵素作用pH4.0下においてさえ蛋白質無添加
区におけるHRP測定限界が5×10‐5ユニットレベ
ルであったのに対し、蛋白質添加区では1×10‐5ユ
ニット(重量換算で38.5pgに相当)の極めて徴量
のHRP迄も測定出来た。この値は無添加区に比較して
数倍、先に示したギルバゥト等の方法の約百数十倍の感
度上昇に相当した。表6
実施例 2:日202の定量
0.1M−クエン酸−Na2B407緩衝液(pH4.
0)500仏夕、HRP(実験例4のRZ:3.4標品
と同じ)の1×10‐1ユニット/の‘液10仏そ、実
施例1に示した母A水溶液または純水の20〃そ、0.
25%−ホモバニリン酸液50ム〆及び下記量のH20
2を含む検液50仏〆から成る酵素反応混合液について
実験例1と同様な操作を施し、下表7の値を得た。In other words, even under enzyme action pH 4.0, the HRP measurement limit in the protein-free plot was 5 x 10-5 units, whereas in the protein-added plot it was 1 x 10-5 units (38.5 pg in weight). It was possible to measure up to a very high level of HRP (equivalent to 20%). This value corresponded to an increase in sensitivity several times compared to the additive-free plot, and about 100-odd times as much as the previously described method of Gilbert et al. Table 6 Example 2: Determination of day 202 0.1M-citric acid-Na2B407 buffer (pH 4.
0) 500 liters of HRP (RZ: 3.4 standard in Experimental Example 4) 1 x 10-1 units/10 liters of mother A aqueous solution or pure water shown in Example 1 20 So, 0.
50 ml of 25% homovanillic acid solution and the following amount of H20
The same operation as in Experimental Example 1 was performed on an enzyme reaction mixture consisting of 50 test solutions containing 2, and the values shown in Table 7 below were obtained.
この際、広0225.0一g/試験管を含み且つBSA
無添加時の蟹光度を100として他の各区の活性を相対
値で示した。即ち、本発明の実施によってHRPの検出
感度が全般的に40〜60%更に高表7
まると共に10‐8gオーダーの均02量の測定が易く
しかも再現性よく可能となって公知の測定法のいずれと
比較しても極めて優れた測定感度や測定の精度を示した
。At this time, contain 0.225.01g/test tube and contain BSA.
The activity of each other group was shown as a relative value, with the crab luminosity when no additives were added as 100. That is, by carrying out the present invention, the detection sensitivity of HRP is generally 40 to 60% higher.It is also possible to easily and reproducibly measure a uniform amount of 10-8 g, compared to known measurement methods. Compared to both, it showed extremely superior measurement sensitivity and measurement accuracy.
Claims (1)
において、酸性下かつペルオキシダーゼ活性を有しない
蛋白質あるいはペプチドの存在下で酵素反応を行わしめ
ることを特徴とするペルオキシダーゼ活性の測定方法。1. A method for measuring peroxidase activity by fluorescence analysis, which comprises carrying out an enzymatic reaction under acidic conditions and in the presence of a protein or peptide that does not have peroxidase activity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8270377A JPS608800B2 (en) | 1977-07-11 | 1977-07-11 | How to measure peroxidase activity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8270377A JPS608800B2 (en) | 1977-07-11 | 1977-07-11 | How to measure peroxidase activity |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5417899A JPS5417899A (en) | 1979-02-09 |
| JPS608800B2 true JPS608800B2 (en) | 1985-03-05 |
Family
ID=13781750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP8270377A Expired JPS608800B2 (en) | 1977-07-11 | 1977-07-11 | How to measure peroxidase activity |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS608800B2 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6143084Y2 (en) * | 1979-09-11 | 1986-12-05 | ||
| JPS608750A (en) * | 1983-06-29 | 1985-01-17 | Yatoron:Kk | Measuring method of serum component |
-
1977
- 1977-07-11 JP JP8270377A patent/JPS608800B2/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5417899A (en) | 1979-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4578361A (en) | Creatinine antibody | |
| EP0770876B1 (en) | A screening method for identifying ligands for target proteins | |
| JPS58757A (en) | Methods for performing isotope-free immunoassays, labeled analytes and kits used for such assays | |
| CN108445230B (en) | Procalcitonin chemiluminescence detection reagent based on nano antibody and detection method | |
| Franck et al. | A specific method for measurement of equine active myeloperoxidase in biological samples and in in vitro tests | |
| US20130273048A1 (en) | Stabilizing agent and blocking agent | |
| JPH0242982A (en) | Stable peroxidase composition and stable antibody composition | |
| US4543325A (en) | Process and reagent for the determination of creatinine | |
| US5780239A (en) | Method for the determination of cast in urine | |
| Ikemoto et al. | Liver-type arginase in serum during and after liver transplantation: a novel index in monitoring conditions of the liver graft and its clinical significance | |
| JPS608800B2 (en) | How to measure peroxidase activity | |
| JP5140814B2 (en) | Antibody stabilization method, immunochromatography method using the method, and plant virus diagnostic kit | |
| CA2148268A1 (en) | Method for specific immunoassay of human plasmatic glutathione peroxidase | |
| FR2601781A1 (en) | MYCOTOXIN ASSAY REAGENT AND METHOD USING THE SAME FOR DOSING MYCOTOXIN | |
| US5137807A (en) | Method for determining beta-subunit of human prolyl 4-hydroxylase by immunoassay to detect hepatic disease | |
| CN110045123A (en) | A kind of carbohydrate antigen 242 magnetic microparticle chemiluminescence immune quantitative detection reagent box and preparation method thereof | |
| Bühler et al. | Quantitation of Alcohol Dehydrogenase in Human Tissue and Serum by an Enzyme‐Linked Immunosorbent Assay (ELISA) | |
| Leaper et al. | Phytochrome control of the accumulation and rate of synthesis of ascorbate oxidase in mustard cotyledons | |
| JP2010044058A (en) | Enzyme immunoassay using enzyme labeled antibody | |
| CA1278989C (en) | Diagnostic assay using microperoxidase | |
| SU1606940A1 (en) | Method of qualitative determination of catalitically active molecules of serine proteinases of bacillae | |
| JPS6146116B2 (en) | ||
| JP2006515763A (en) | Novel method for measuring the activity of an enzyme using or producing prostaglandin endoperoxide H2 | |
| CN120847391A (en) | Sample diluent, application thereof, and kit | |
| CN103616506B (en) | Enzyme label antibody reagent |